Please login to the form below

Not currently logged in


This page shows the latest relugolix news and features for those working in and with pharma, biotech and healthcare.

AbbVie files blockbuster hopeful elagolix for uterine fibroids

AbbVie files blockbuster hopeful elagolix for uterine fibroids

However, AbbVie is facing some competition in the category from Myovant’s rival drug relugolix, which has just chalked up positive phase 3 trials in uterine fibroids and will set up ... Phil Nadeau – thinks it can and that relugolix will become a $1bn

Latest news

More from news
Approximately 1 fully matching, plus 7 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

Alzheimers incidence
A roadmap to the successful treatment of Alzheimer’s disease
Building on past research to learn more about the disease and how to treat it...
Article: Like, Like, Like: Harnessing the power of social media insights
Its Know Your Numbers week
Do you know yours?...